Physician profile
Marisel Vazquez-Correa
NPI 1164482865
$653.05
in general payments reported to CMS, 2019-2025
12 companies · $25.00 in 2025
The $25.00 reported for 2025 was less than what a typical Neurodevelopmental Disabilities (Pediatrics) provider received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.07 · 2020: $131 · 2021: $12.51 · 2022: $26.73 · 2023: $309 · 2024: $99.77 · 2025: $25.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $141.67 | 2023 | Valtoco |
| Biomarin Pharmaceutical INC. | $103.31 | 2020 | |
| Acadia Pharmaceuticals INC | $95.43 | 2023 | Daybue |
| Novartis Pharmaceuticals Corporation | $56.70 | 2024 | |
| Jazz Pharmaceuticals INC. | $51.73 | 2022-2025 | |
| Emd Serono, INC. | $46.61 | 2023 | Mavenclad |
| Merck Sharp & Dohme LLC | $41.57 | 2023-2024 | Gardasil 9, Rotateq, Gardasil |
| Alexion Pharmaceuticals, INC. | $34.88 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.95 | 2020 | |
| Ptc Therapeutics, INC. | $26.50 | 2024 | Emflaza |
| Ucb, INC. | $14.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marisel Vazquez-Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.